30
Participants
Start Date
December 30, 2019
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
Niraparib
Niraparib (\[3S\]-3-\[4-{7-(aminocarbonyl)-2H-indazol-2-yl} phenyl\] piperidine \[tosylate monohydrate salt\]) is an orally available, potent, highly selective poly (adenosine diphosphate \[ADP\]-ribose) polymerase (PARP) -1 and -2 inhibitor. The niraparib drug product is provided as 100-mg capsules filled with a dry blend of niraparib tosylate monohydrate, lactose monohydrate, and magnesium stearate in a hard gelatin capsule.
Optune
"Optune, which is manufactured by Novocure, is a portable battery or power supply operated device which produces alternating electrical fields, called tumor treatment fields (TTFields) within the human body. TTFields are applied to the patient by electrically-insulated surface transducer arrays. TTFields disrupt the rapid cell division exhibited by cancer cells."
Planned surgical resection
Surgery of supratentorial glioblastoma (GBM).
Hospital of the University of Pennsylvania, Philadelphia
Tesaro, Inc.
INDUSTRY
NovoCure Ltd.
INDUSTRY
University of Pennsylvania
OTHER